Sherry Shao
Tracked across 4 events · 29 articles · First seen Apr 09, 2026 · Last active Aug 18, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: Sherry Shao, Rotating CEO of GenScript Biotech Corporation, emphasized the company's integration of sustainability into its growth strategy, reinforcing its commitment to long-term value creation.
Apr 14, 2026 · 6 articles
Business
GenScript Biotech Corporation reported first-half 2026 revenue of approximately US$404.2 million, up 27.3% year over year, and adjusted net profit of approximately US$62.5 million, up 203.3%. The AI-enabled drug discovery business doubled year over year…
Impact: As Rotating CEO, commented on the company's strong execution and long-term opportunity in AI-enabled drug discovery, reinforcing leadership confidence.
Jul 20, 2026 · 7 articles
Tech
Impact: Sherry Shao, GenScript Biotech Corporation's Rotating CEO, commented on the significance of the TurboCHO Protein Expression Kit in advancing science and bringing new medicines to patients faster.
May 12, 2026 · 8 articles
ERGEN INTELLIGENCE
Track Sherry Shao live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard